[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 41, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 935085, "exercisedValue": 0, "unexercisedValue": 1146738}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 75357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 905415, "exercisedValue": 0, "unexercisedValue": 1402731}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 40, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1984, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 51, "title": "Chief People Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.25, "open": 1.3, "dayLow": 1.2401, "dayHigh": 1.3032, "regularMarketPreviousClose": 1.25, "regularMarketOpen": 1.3, "regularMarketDayLow": 1.2401, "regularMarketDayHigh": 1.3032, "payoutRatio": 0.0, "beta": -0.259, "forwardPE": -0.7743902, "volume": 60726, "regularMarketVolume": 60726, "averageVolume": 235258, "averageVolume10days": 156790, "averageDailyVolume10Day": 156790, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 45576872, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 3.83, "fiftyDayAverage": 1.5902, "twoHundredDayAverage": 1.7554, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13594947, "profitMargins": 0.0, "floatShares": 27234477, "sharesOutstanding": 35887300, "sharesShort": 1067482, "sharesShortPriorMonth": 1627849, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0297, "heldPercentInsiders": 0.24065, "heldPercentInstitutions": 0.119049996, "shortRatio": 5.55, "shortPercentOfFloat": 0.0377, "impliedSharesOutstanding": 35887300, "bookValue": 1.333, "priceToBook": 0.9527382, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -61036608, "trailingEps": -2.04, "forwardEps": -1.64, "enterpriseToEbitda": -0.213, "52WeekChange": -0.2616279, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.27, "targetHighPrice": 25.0, "targetLowPrice": 1.5, "targetMeanPrice": 11.7, "targetMedianPrice": 12.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 36144720, "totalCashPerShare": 1.007, "ebitda": -63686328, "totalDebt": 4162857, "quickRatio": 4.817, "currentRatio": 5.276, "debtToEquity": 10.059, "returnOnAssets": -0.51571, "returnOnEquity": -0.92506, "freeCashflow": -33647992, "operatingCashflow": -54999572, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 235258, "fiftyTwoWeekLowChange": 0.26999998, "fiftyTwoWeekLowChangePercent": 0.26999998, "fiftyTwoWeekRange": "1.0 - 3.83", "fiftyTwoWeekHighChange": -2.56, "fiftyTwoWeekHighChangePercent": -0.6684073, "fiftyTwoWeekChangePercent": -26.162792, "epsTrailingTwelveMonths": -2.04, "epsForward": -1.64, "epsCurrentYear": -1.95333, "priceEpsCurrentYear": -0.65017176, "fiftyDayAverageChange": -0.32019997, "fiftyDayAverageChangePercent": -0.2013583, "twoHundredDayAverageChange": -0.48539996, "twoHundredDayAverageChangePercent": -0.27651817, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "regularMarketChangePercent": 1.5999984, "regularMarketPrice": 1.27, "corporateActions": [], "postMarketTime": 1744933366, "regularMarketTime": 1744920001, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 2.24409, "postMarketPrice": 1.2985, "postMarketChange": 0.0285, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.2401 - 1.3032", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]